Laura Villars, Swiss racing driver, becomes the first woman to run for FIA President
PARIS, Sept. 18, 2025 /PRNewswire/ -- Laura Villars, Swiss racing driver aged…
Wynn Redefines the Luxury Exhibition Experience with the Return of the “Wynn Signature – 2025 Hypercar Exhibition”
MACAO, Sept. 12, 2025 /PRNewswire/ -- Wynn is set to transform the…
Newest Innovation in Protein: Proathlix’s 9-Source Protein Blend with Veg Collagen Peptide
A Revolution in Multi-Source Protein Supplementation Backed by Real Performance NEW DELHI,…
Tecan issues CHF 150 million straight bond
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO…
Art of Time: A Decade of Horological Excellence
Art of Time celebrates a decade of shaping India's luxury watch landscape…
Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules…
vVARDIS Drill-Free Solution Curodont Has Treated Over One Million Teeth in 18 Months and Is the Fastest Growing Dental Care Product in Its Category
Clinical adoption of Curodont™ is helping to elevate the standard of care…
![Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]](https://i0.wp.com/ml-eu.globenewswire.com/media/NjEzMmQ4NzAtZTBkMS00ZDhhLTkyYjgtOGM3YzY1ZWM5M2U5LTEwMTQyODItMjAyNS0wNi0wMi1lbg==/tiny/Sandoz-International-GmbH.png?w=420&resize=420,280&ssl=1 "Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]")
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA…